Guidelines for approving a coronavirus vaccine will be the focus of FDA advisers meeting Thursday

A Food and Drug Administration panel is scheduled to hold a milestone meeting to kick off the complicated process of vetting the safety and effectiveness of vaccines against the novel coronavirus.

Comments are closed.